This study, published in Epidemiology, investigates the impact of hormone replacement therapy (HRT) on breast cancer risk in postmenopausal women, focusing on those with a family history of breast cancer. The study followed 16,608 participants who were randomized to receive either estrogen plus progesterone therapy or a placebo. Results showed
